Top 3 innovations in diabetes management of cats

The recent progress in the treatment of diabetes in cats include remarkable developments such as the introduction of SGLT2 inhibitors, the availability of ultra-long-effective insulin and the increasing use of continuous glucose measurement systems (CGM). These innovations considerably make it considerable for veterinarians and cat owners.

Image from Pikabum on Pixabay

introduction

1. SGLT2 inhibitor :
   By market approval of Bexagliflozin tablets and the Velagliflozin solution, a new class of medication is available that block the recessorption of glucose in the kidneys and thus lower the blood sugar level. Thanks to their oral administration, the low hypogly gaming risk and its proven effectiveness, these drugs could represent a sensible alternative for certain cats with newly diagnosed diabetes.
2. Ultra-long-effective insulin :
   The development of ultra-long-effective insulin, such as insulin glargin U300 and insulin degludec, offers more stable blood sugar control with less daily injections. Although further studies are necessary to determine the ideal dosage and frequency of application for cats, the first results show promising approaches to optimize insulin management in Felinem diabetes.
3. Continuous glucose measurement (CGM) :
   CGM systems enable animal owners and veterinarians to precisely monitor the glucose course of a cat over several days without frequent blood samples. This reduces stress for the animal and provides more comprehensive data to adapt the treatment. The improved accuracy of the current sensors, combined with their user -friendliness, has made CGM a valuable tool in diabetes treatment.

What are SGLT2 inhibitors?

SGLT2 inhibitors, short for sodium glucose co-transporter-2 inhibitors , are a relatively new class of drugs that were originally developed to treat type 2 diabetes in humans. Their mechanism of action is based on the targeted inhibition of the sodium glucose co-transporter type 2 (SGLT2), which is mainly in the kidneys.

Usually glucose from the primary urine in the proximal tubulus of the kidney is absorbed back into the bloodstream, whereby SGLT2 is responsible for the majority of this resistance. If SGLT2 is blocked, the glucose from the primary urine can no longer be completely returned to the body. Instead, she is excreted over the urine. This effect leads to a reduction in blood sugar levels because less glucose remains in the blood.

In addition to reducing blood sugar levels, SGLT2 inhibitors have other potentially positive effects. In humans, for example, favorable effects on body weight and blood pressure could also be demonstrated, since the excretion of glucose via the urine is also associated with a loss of calories. Whether these advantages appear in a similar way in cats will continue to be examined.

An important advantage of the SGLT2 inhibitors is that compared to other anti-diabetic drugs, they have a lower risk of severe hypoglycaemia (low blood sugar levels). This is because your mechanism of action works regardless of insulin production. The inhibition of SGLT2 simply means that more glucose is excreted, regardless of how much insulin the body produces. However, it is important to note that complete insulin addiction (for example in the case of insulin -dependent diabetes) can increase the risk of so -called euglycemic ketoacidosis, since glucose is not efficiently absorbed into the cells.

In veterinary medicine, SGLT2 inhibitors are currently being examined primarily for newly diagnosed diabetes in cats, especially in animals that still have a certain in-house production of insulin. However, clinical use requires a careful selection of patients, since existing diseases such as kidney or liver failure as well as gastrointestinal problems can affect the compatibility and safety of therapy.

In summary, SGLT2 inhibitors are an innovative treatment option for diabetes based on the blockade of a central transport mechanism in the kidney. This inhibition excretes glucose over the urine, which lowers blood sugar levels without intervene directly into the insulin mechanism. Your application in veterinary medicine is promising, but still requires intensive research and careful clinical surveillance.

Ultra-long-effective insulin

Ultra-long-effective insulins are a special form of insulin preparations, which are characterized by a particularly long duration of action and more stable blood sugar control. Their main advantage is that you maintain an even insulin level for many hours, which makes you attractive as basal insulins. While traditional insulins often have to be injected several times a day and can sometimes cause considerable fluctuations in blood sugar levels, ultra-long-effective insulin offer a more reliable and predictable glucose control.

Development and mode of action:
The concept of ultra-long-effective insulin emerged from the need to enable patients- both in human and veterinary medicine- more comfortable and more even blood sugar regulation. The first basal insulins, such as Insulin Glargin U100, already had an extended duration of action compared to short or medium-long insulins. Ultra-long-effective insulins such as Insulin Glargin U300 and Insulin Degludec go one step further: They are formulated in such a way that the insulin is continuously released over an even longer period (sometimes up to 24 hours or more). This is achieved by modifications in the insulin structure or by the type of suspension in which the insulin is solved.

Pharmacinetics and pharmacodynamics:
The impact profiles of ultra-long-effective insulin often show a reduced fluctuation within a day. This means that the insulin level remains relatively constant and there are no strong tips or lows, as can be observed in short -effective insulins or meal insulins. A more uniform insulin release reduces the risk of hypoglycaemia and can help keep the blood sugar level stable over longer periods.

Another characteristic feature of ultra-long-effective insulin is its extended half-life. While earlier basal insulins may only have been effective for 12 to 16 hours, modern ultra-long-effective preparations can have up to 42 hours, depending on the dosage and the individual physiology of the patient. This extended duration of action means that often only one daily injection is required, which improves the loyalty to therapy in patients and simplifies handling for owners of pets.

Advantages over conventional insulins:

1. More constant blood sugar control:
   Ultra-long-effective insulins offer a flatter profile, which means that the insulin concentration remains relatively stable throughout the day. This helps to avoid large blood sugar fluctuations that can lead to symptoms such as sleepiness or discomfort.
2. Reduced risk of hypoglycaemia:
   Since ultra-long-effective insulins do not have a pronounced tips in their effect, there is a lower risk that blood sugar will drop too much. This is particularly important for sensitive patients or those with irregular feeding behavior.
3. Salved therapy planning:
   With an extended duration of action, many patients (both human and animal) can get by with only one injection per day. This reduces the effort for the owners and improves the quality of life of animal and humans alike.

Use in cats with diabetes:
The use of ultra-long-effective insulin in cats with diabetes is a promising approach, although there are still relatively few studies. Cats have a relatively constant insulin secretion by nature compared to other species. Therefore, ultra-long-effective insulins that offer even basal insulin supply could be particularly advantageous for cats. Insulin Glargin U300, for example, shows a longer duration of action in cats and more stable blood sugar control compared to conventional basal insulins. Insulin Degludec, another ultra-long-effective preparation, also offers advantages, but with a somewhat shorter duration of action as an insulin glargin U300.

Challenges and future perspectives:
Despite the advantages, there are also challenges when using ultra-long-effective insulins, especially in cats. The individual response to these preparations can vary, and it is often necessary to adapt to the optimal dosage. In addition, factors such as comorbidities, eating habits and activity levels can influence the insulin effect. Long -term studies and other clinical experiences will help to determine the best use of this insulin in cats.

Ultra-long-effective insulins represent significant progress in the treatment of diabetes. They offer more stable blood sugar control, reduce the risk of hypoglycaemia and make therapy easier and more comfortable. You can represent a promising option for cats with diabetes, especially if an even and long -lasting insulin supply is required. Future studies and experiences will show how these innovative insulin can best be used in practice in order to maximize the well -being and quality of life of the animals concerned.

Continuous glucose measurement

The continuous glucose measurement (English: Continuous Glucose Monitoring, CGM) is a modern method to monitor glucose value in the body over a longer period of time. It differs fundamentally from the conventional blood sugar measurements, which are carried out with a glucometer and a drop of blood by continuously providing data about the glucose course and thus enables a more complete image of blood sugar control.

Basic principle and functionality:
A CGM system usually consists of three main components:

1. A sensor:
   The sensor is inserted under the skin and measures the glucose content in the interstitial liquid - a liquid that is in the tissue between the body cells. This measurement is not carried out directly in the blood, but in the tissue, which results in a somewhat time -shifted (usually only a few minutes) display of the glucose mirror.
2. A transmitter:
   The transmitter sits on the skin surface and is connected to the sensor. He receives the data from the sensor and sends it wirelessly to an display device.
3. A receiver or display device:
   The measured glucose values ​​are displayed in real time on a special reader or a smartphone app. Some systems can also spend warnings if the glucose values ​​exceed a certain limit or are below a critical area.

The sensor remains in the same place over a longer period of time (typically several days up to two weeks). During this time, he regularly records glucose values ​​- often every five minutes - and provides a continuous profile of the glucose course.

Advantages of continuous glucose measurement:

1. More comprehensive database:
   Unlike selective measurements with a conventional glucometer, a CGM system offers a complete overview of glucose courses. This helps to recognize trends and patterns, such as: B. Nocturnal hypoglycaemia or climbs after meals, which may remain undetected at individual measurements.
2. Better management of diabetes:
   Thanks to the continuous data, patients and veterinarians can make more and more informed decisions regarding the adaptation of medication, nutritional plans or insulin regimes. The early detection of problematic glucose trends also enables timely countermeasures.
3. Reduced measurement volume:
   A CGM system does not require multiple finger stitches a day. Instead, the sensor continuously provides values, which causes patients to experience less stress and inconvenience.
4. Warning functions:
   Many CGM systems offer alarms that warn users if the glucose value is too high or too low. These warnings can be particularly valuable to prevent dangerous conditions such as hypoglycaemia.

Possibilities in veterinary medicine:
CGM systems are not only used in people with diabetes, but are also increasingly being used in veterinary medicine, especially in cats and dogs with diabetes. The advantages are similar to humans:

• Minimized stress for the animal: the continuous measurement reduces the need for frequent blood samples.
• Monitoring in the usual environment: animal owners can watch the glucose course of their animal at home without constantly being necessary visits to the vet .
• Long -term data analysis: The data collected for days enables the vet to make a more precise assessment of therapy efficiency and possible adjustments.

Challenges and restrictions:
Despite the advantages, there are also some aspects that must be taken into account when using CGM systems:

• Delay in the measurement: Since the measurement takes place in the interstitial liquid, the value is behind about 5–15 minutes compared to blood glucose. This is particularly relevant for quick changes in blood sugar levels.
• Correct placement and durability of the sensor: The sensor must be placed at a suitable place and sit safely. Especially with active animals, it can be difficult to keep the sensor on the spot.
• Costs: CGM systems are often more expensive than conventional measurement methods in the purchase and ongoing operation, which can be a financial hurdle for some owners.

Future perspectives:
The technology of continuous glucose measurement is constantly being developed. Newer sensors are getting smaller, more precise and more user -friendly. Future generations of CGM systems could even be portable for longer, offer even better accuracy and automatically communicate with insulin pumps in order to regulate the glucose level in real time. Especially in veterinary medicine, this progress could help to further facilitate diabetes management for animal owners and animals.

The continuous glucose measurement is an innovative approach that is used in both human medicine and increasingly in veterinary medicine. The continuous recording of glucose data enables more precise and individual adjustment of diabetes treatment, reduces stress due to frequent blood samples and improves blood sugar control in the long term. CGM is a promising option in particular for cats and dogs with diabetes to increase the quality of life and make therapy more efficient.

Which cat is suitable for diabetes management of cats for?

The selection of the best therapy method for a cat with diabetes mellitus depends on a number of individual factors. Each cat has its own physiological and health conditions that influence the suitability of certain forms of treatment. The various options for diabetes treatment for cats and their advantages and disadvantages in different clinical scenarios are described below.

1. Sglt2-inhibitor (e.g. Bexagliflozin, Velagliflozin)
particularly suitable for:

• Cats with newly diagnosed diabetes: cats that still have sufficient in-house production of insulin and where there is still no insulin dependency, often benefit from SGLT2 inhibitors. These drugs reduce blood sugar through the increased excretion of glucose via the kidneys without directly inserting insulin metabolism.
• Cats without serious comorbidities: Since SGLT2 inhibitors can be a certain burden on the kidneys, they are particularly suitable for cats with healthy kidney functions and without severe gastrointestinal or hepatic problems.
• Owners who prefer daily administration once: SGLT2 inhibitors are administered orally and usually only have to be given once a day. This can be particularly advantageous for owners who have difficulty administering medication more often.

Less suitable for:

• Cats with an insulin-dependent diabetes: If the cat hardly or no longer has its own insulin production, there is an increased risk of euglycemic ketoacids, since SGLT2 inhibitors do not promote cellular glucose entry.
• Cats with kidney or liver diseases: Cats with existing kidney dysfunction or significant liver problems should not receive SGLT2 inhibitors, since these medication can increase the kidney load and may cause gastrointestinal side effects.
• Seriously ill or clinically unstable cats: cats suffering from chronic vomiting, loss of appetite or other systemic complaints are not good candidates for this form of therapy, since the body is dependent on more stable insulin supply in such conditions.

2. Ultra-long-effective insulin (e.g. Insulin Glargin U300, Insulin Degludec)
particularly suitable for:

• Cats with a stable underlying disease and good general condition: Ultra-long-effective insulins offer more even basal supply, which is particularly advantageous in cats with stable metabolic states.
• Cats with mild fluctuations in blood sugar levels: Since ultra-long-effective insulins have a relatively flat effective profile curve, they are suitable for animals that show no abrupt and strong fluctuations in blood sugar levels.
• Cats with an already established insulin therapy that had difficult control problems: In cats that were difficult to adjust with traditional insulins, a switch to ultra-long-effective insulins can lead to a more stable blood sugar control.
• Owners who want to inject less often: Ultra-long-effective insulins can often be administered daily, which reduces stress for both the animal and the owner.

Less suitable for:

• Cats with very irregular eating habits: Cats who often eat small amounts at different times can possibly benefit from insulins with a shorter effect that can be easily adapted to irregular feeding times.
• Cats with pronounced hyperglycemia tips after meals: Since ultra-long-effective insulins cover the basal supply, they can be less effective in cats with high postprandial blood sugar peaks. In such cases, combination therapies or insulins are more sensible with a faster occurrence.
• Cats with extremely short insulin effect: Some cats metabolize insulin very quickly, which means that even ultra-long-effective preparations may not achieve the desired long-lasting effect.

3. Continuous glucose measurement (CGM)
particularly suitable for:

• Cats with difficult to adjust diabetes: cats whose blood sugar levels fluctuate heavily or who react badly to conventional dosage adjustments benefit from the detailed glucose curve that provides a CGM system.
• Cats whose owners want precise data: For owners who want to understand and monitor the blood sugar course of their animal, a CGM system offers valuable insights and enables a sound adjustment of the therapy.
• Cats that are afraid of frequent stabbing: Since CGM systems do without daily blood from daily, they are particularly suitable for cats who have stress or fear of regular blood samples.
• Cats in the initial phase of insulin therapy: During the initial setting phase, a CGM system provides a comprehensive overview of the course of the glucose, which enables more precise adjustment of insulin dose.

Less suitable for:

• Cats with a very active lifestyle: With very active or movement -loving cats, it can be difficult to keep the sensor safely in place.
• Cats with sensitive skin or allergies: Some animals are sensitive to the sensor or the paving materials, which can lead to skin irritation.
• Cats with very stable diabetes: If a cat is already well adjusted and only rarely needs adjustments, a CGM system could be unnecessary, since the added value is limited in such cases.

The choice of the right therapy method should always be made individually. SGLT2 inhibitors are ideal for cats with newly diagnosed diabetes and good organ function, while ultra-long-effective insulins enable more stable long-term control. CGM systems are particularly valuable for difficult to adjust or sensitive cats. The specific needs and health states of the cat as well as the practical possibilities of the owner should always focus on the decision.

Frequent questions about diabetes management of cats

Summary Diabetes Management of Cats

The diabetes management of cats is a comprehensive approach that includes a variety of measures to stabilize and improve the health of cats with diabetes mellitus. The focus of diabetes management of cats is the reduction and stabilization of blood sugar levels, which often requires a combination of drug therapy, nutritional adjustment, regular monitoring and veterinary care. One of the most important pillars of diabetes management of cats is the use of insulin, which can either be administered in conventional or ultra-long-effective form. The selection of the appropriate insulin type and the determination of the right dosage are crucial for successful diabetes management of cats, since these factors have direct effects on blood sugar and the general quality of life of the cat.

Another central aspect in diabetes management of cats is the continuous monitoring of the glucose values. Through the use of modern technologies such as continuous glucose measurement systems (CGM), animal owners and veterinarians can receive detailed data about the blood sugar curve. This information helps to adapt the therapy and to assess the effectiveness of the chosen treatment plan. The diabetes management of cats also includes regular control of blood sugar, fructosamin levels and other relevant parameters to ensure that the disease remains under control and no complications occur.

Diet in diabetes management of cats also plays an important role. The use of special diet feed that is tailored to the special needs of diabetic cats is an essential part of diabetes management of cats. These diets are often low in carbohydrates and rich in protein, which contributes to avoiding postprandial blood sugar tips and promoting insulin sensitivity. Due to diabetes management of cats can also be better controlled by the body's body weight, which significantly influences the overall situation of the disease. In many cases, a successful change in diet in the context of diabetes management of cats leads to a noticeable improvement in the metabolic values ​​and the general well -being of the cat.

In addition to drug therapy and nutritional adjustment, the diabetes management of cats also includes taking comorbidities into account. Common comorbidities such as obesity, infections or other hormonal disorders can affect the course of diabetes. A comprehensive diabetes management of cats ensures that these comorbidities are recognized and treated accordingly to ensure the stability of blood sugar levels and to improve the quality of life of the cat in the long term. A thorough examination and diagnostic clarification form the basis for effective diabetes management of cats because they enable them to develop individually adapted treatment strategies.

The diabetes management of cats requires close cooperation between the veterinarian and animal owner. The veterinarian takes over the regular monitoring and adaptation of the therapy, while the animal owner plays an important role in the daily implementation of diabetes management of cats. This includes the correct administration of insulin, observation of changes in the behavior of the cat and the compliance with feeding and monitoring plans. A successful diabetes management of cats therefore depends on the training and motivation of the animal owners, since they have to consistently implement the measures at home.

In addition, the diabetes management of cats includes preventive and long -term care. As soon as the blood sugar is stabilized, the diabetes management of cats aims to avoid possible relapses or complications. Regular check -ups and adjustments to the treatment plan help to keep diabetes under control in the long run. As part of the diabetes management of cats, care is also taken to minimize stress and to design the cat's living environment in such a way that it feels comfortable and healthy.

In summary, the diabetes management of cats is a comprehensive approach that combines drug therapies, nutritional management, continuous monitoring, the treatment of companions and close cooperation between veterinarian and animal owner. Successful diabetes management of cats helps to improve the quality of life, avoid complications and enable the cat to live as healthy and active.

In the ongoing diabetes management of cats, it is also important to react flexibly to changes in the cat's health. Diabetes is not a static disease, but requires continuous adjustments and fine votes to ensure that therapy remains successful in the long term. As part of diabetes management of cats, this means to regularly consider the current research results and new treatment options. Advances in the development of insulins, anti -diabetics or measuring systems can make diabetes management easier and help to further improve treatment.

Another focus is on observing the behavior and quality of life of the cat. A successful diabetes management of cats is not only shown in stable blood sugar levels, but also in improved vitality, healthy weight and a generally happier lifestyle of the cat. Pet owners should pay attention to how the cat eats, sleeps, plays and reacts to stress as part of the diabetes management of cats. Changes in these behaviors can indicate problems or necessary therapy adjustments at an early stage.

In addition, the long -term motivation of the animal owners plays a key role in diabetes management of cats. Since it is a chronic illness, the commitment of the owners is crucial to continuously implement the necessary measures. Veterinarians should not only convey medical knowledge as part of diabetes management, but also give psychological support and practical tips to facilitate everyday life with a diabetic cat. A positive attitude and good communication between the vet and animal owners are essential factors for the success of diabetes management of cats.

Finally, the diabetes management of cats can be understood as a kind of dynamic process that includes both medical and interpersonal components. With a well thought -out approach that is checked and adapted regularly, the diabetes management of cats enables long -term control of the disease and an improved quality of life for the cat concerned. With the combination of modern medicine, attentive care and a committed pet owner, a stable state can be achieved, which enables the cat a fulfilling life despite diabetes.

, etc.